LOINC parts

72,372 parts · page 617 of 1,448 · all codes

PartNameTypeTests
LP266734-5 Episode COMPONENT 1
LP266735-2 Trend COMPONENT 1
LP266737-8 Exudate COMPONENT 1
LP266738-6 Area of wound bed COMPONENT
LP266739-4 Area of identified wound bed color COMPONENT
LP266741-0 Wound bed panel COMPONENT 1
LP266742-8 Wound edge panel COMPONENT 1
LP266743-6 Wound tunneling panel COMPONENT 1
LP266744-4 Wound undermining panel COMPONENT 1
LP266745-1 Drug regimen review identified potential medication issues in the last 3 days COMPONENT 1
LP266747-7 Medication follow-up in the last 3 days COMPONENT 1
LP266748-5 Acute kidney injury risk COMPONENT 1
LP266749-3 IRF-PAI v2.0 - Medications - admission COMPONENT 1
LP266750-1 Bacterial 23S rRNA gene azithromycin resistance mutation COMPONENT 1
LP266751-9 Area of wound COMPONENT 1
LP266752-7 Tender joint COMPONENT 2
LP266753-5 Swollen joint COMPONENT 2
LP266756-8 Rheumatoid arthritis disease activity level COMPONENT 1
LP266759-2 Buprenorphine-3-glucuronide COMPONENT 2
LP266760-0 Norbuprenorphine-3-glucuronide COMPONENT 2
LP266761-8 Insulin intact COMPONENT 1
LP266763-4 Varicella zoster virus Ab.IgM+total COMPONENT 1
LP266765-9 SURVEY.BDI CLASS
LP266766-7 PANEL.SURVEY.BDI CLASS
LP266767-5 Beck Depression Inventory II COMPONENT 1
LP266769-1 Beck Depression Inventory Fast Screen COMPONENT 1
LP266770-9 Patient Health Questionnaire - 9 Modified for Teens METHOD 2
LP266771-7 Center for Epidemiologic Studies Depression Scale-Revised METHOD 2
LP266772-5 Center for Epidemiologic Studies Depression Scale-Revised COMPONENT 1
LP266773-3 SURVEY.CESD CLASS
LP266774-1 PANEL.SURVEY.CESD CLASS
LP266775-8 Patient Health Questionnaire-9: Modified for Teens COMPONENT 1
LP266776-6 FDA-initiated compliance action drug registration and listing inactivation COMPONENT 1
LP266778-2 Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness METHOD 13
LP266786-5 Severe bleeding related to aspirin use COMPONENT 1
LP266787-3 Willing to change aspirin dose COMPONENT 1
LP266789-9 Satisfaction with using ADAPTABLE web site COMPONENT 1
LP266790-7 Adequacy of information on+time spent reading ADAPTABLE web site COMPONENT 1
LP266791-5 Permission to receive text messages COMPONENT 1
LP266792-3 Insurance group number COMPONENT 1
LP266797-2 Enteric coated aspirin tablet COMPONENT 1
LP266799-8 Blood thinning medication use COMPONENT
LP266800-4 Type of nonsteroidal anti-inflammatory drugs (NSAIDs) used several times a week COMPONENT 1
LP266801-2 Type of medication used for stomach upset COMPONENT 1
LP266803-8 Year aspirin regimen began COMPONENT 1
LP266805-3 Reason for discontinuing aspirin use COMPONENT 1
LP266806-1 Line blot METHOD 225
LP266807-9 BRAF gene V600 mutations COMPONENT 2
LP266808-7 MDS v3.0 - RAI v1.16.1 - Nursing home discharge (ND) and Swing bed discharge (SD) item set COMPONENT 1
LP266809-5 MDS v3.0 - RAI v1.16.1 - Nursing home OMRA start of therapy and discharge (NSD) and Swing bed OMRA start of therapy and discharge (SSD) item set COMPONENT 1

← prev · next →